Jennifer R Brown

69PUBLICATIONS

304CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Liquid biopsiesMolecular targets

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (69)

Sort by Publication Date:

|Jun 23, 2026

SAVE, Safe Accelerated Venetoclax Escalation: A phase Ib study of obinutuzumab plus venetoclax with daily ramp-up in CLL.

|May 29, 2026

IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomas.

|May 14, 2026

A Comprehensive Review of the Role of Zanubrutinib for Patients with Chronic Lymphocytic Leukemia.

|Apr 09, 2026

Ibrutinib: 10 years and counting.

Jennifer R Brown

|Mar 31, 2026

Final phase 2 study results of acalabrutinib in treatment-naive and relapsed/refractory chronic lymphocytic leukemia.

Richard R Furman, William G Wierda, Piers Em Patten

|Mar 30, 2026

A renaissance in targeting the PI3K/AKT/mTOR pathway.

Sarah E Conduit, Neil Vasan, Jennifer R Brown

Pageof 12

Frequent Collaborators

11 joint publications

Svitlana Tyekucheva

10 joint publications

Paolo Ghia

Matthew S Davids

Constantine Tam

Mazyar Shadman

Jennifer L Crombie

Martin Šimkovič

Jennifer A Woyach

John-Hanson Machado

Tadeusz Robak

Frequent Collaborators

11 joint publications

Svitlana Tyekucheva

10 joint publications

Paolo Ghia

9 joint publications

Matthew S Davids

8 joint publications

Constantine Tam